Roche Holding AG

Pharmaceuticals
RHHBY
$ 40 0.62
Share price
$ 282 bn
Market Cap
$ 319 bn
Enterprise Value

Carbon footprint

1.3 Ton
GHG emissions per $ 1 mln investment
0.05x the weighted average for S&P 500
FY2021
How is this calculated?
-5.2%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-3.4%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -5.1% weighted average for S&P 500
FY2022
How is this calculated?

Roche Holding AG aims to achieve net zero for Scope 1 + 2 by 2050


This target has not been verified as science based according to SBTi
Roche Holding AG's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Roche Holding AG's GHG emissions (market-based) (Kt of CO2e)
Roche Holding AG's Carbon intensity (Tons per 1 USDm)

Roche Holding AG's carbon footprint

Roche Holding AG reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 423 Kt (-23 /-5.2% y-o-y). Also positively, carbon intensity decreased to 5.9 t (-0.9 /-13.2% y-o-y).

Roche Holding AG's Scope 3 emissions surged to 7,898 Kt (+7,841/+13772% y-o-y). The performance has been erratic recently.

The company is committed to achieving net zero for Scope 1 + 2 by 2050, which translates into the estimated reduction of -15 Kt per annum over the period of FY2022 - FY2050. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...